Pagé N, de Jaham C, Paradis M
Départment de sciences cliniques, Faculté de médecine vétérinaire, Université de Montréal, Québec.
Can Vet J. 2000 Oct;41(10):773-6.
The purpose of this study was to observe the efficacy of a topical pour-on formulation of ivermectin in the treatment of otoacariosis, cheyletiellosis, and toxocariosis in cats. Forty-five cats were treated. All cats received 2 to 4 topical applications of ivermectin on the skin between the shoulder blades in a narrow strip, 14 days apart. This practical treatment was effective in 96% (23/24) of cases of feline otoacariosis and in 100% (20/20) of cats with toxocariosis. All cats with cheyletiellosis (16/16) received 4 treatments and had resolution of clinical signs, but one Cheyletiella egg could still be found 45 days after the last treatment. The viability of this egg could not be evaluated, but the cats were still free of clinical signs on follow-up 6 months later. The treatment was well tolerated in all the animals. A few cats developed a transient small alopecic area and mild scaling at the site of application of the drug.
本研究的目的是观察伊维菌素局部浇泼剂治疗猫耳螨病、疥螨病和弓首蛔虫病的疗效。对45只猫进行了治疗。所有猫均在肩胛骨之间的皮肤上以窄条形式局部应用伊维菌素2至4次,每次间隔14天。这种实际治疗方法对96%(23/24)的猫耳螨病病例和100%(20/20)的弓首蛔虫病猫有效。所有患疥螨病的猫(16/16)均接受了4次治疗,临床症状均得到缓解,但在最后一次治疗45天后仍能发现1个疥螨卵。该卵的活力无法评估,但在6个月后的随访中,这些猫仍无临床症状。所有动物对该治疗耐受性良好。少数猫在药物应用部位出现了短暂的小面积脱毛和轻度脱屑。